Phylos Bioscience

Portland, United States Founded: 2014 • Age: 12 yrs
Developer of cannabis breeding tools for agriculture other health purposes
Request Access

About Phylos Bioscience

Phylos Bioscience is a company based in Portland (United States) founded in 2014 by Nishan Karassik.. Phylos Bioscience has raised $32 million across 12 funding rounds from investors including Organigram, Merida Capital Partners and Accomplice. The company has 61 employees as of December 31, 2020. Phylos Bioscience offers products and services including F1 Hybrid Seeds and Natural THCV Products. Phylos Bioscience operates in a competitive market with competitors including Benson Hill, Cibus, Ceres, Pairwise and Inari, among others.

  • Headquarter Portland, United States
  • Employees 61 as on 31 Dec, 2020
  • Founders Nishan Karassik
  • Sectors
    Healthcare
    Agriculture
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Phylos Bioscience, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Agriculture → Forestry & Sustainable Resources
Healthcare → Health Technology & Digital Health
Agriculture → Agricultural Technology & Innovation
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $32 M (USD)

    in 12 rounds

  • Latest Funding Round
    $3 M (USD), Series B

    Dec 31, 2025

  • Investors
    Organigram

    & 3 more

  • Employee Count
    61

    as on Dec 31, 2020

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Phylos Bioscience

Phylos Bioscience offers a comprehensive portfolio of products and services, including F1 Hybrid Seeds and Natural THCV Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Seeds for high-THC cannabis with uniform growth and cost savings.

Enhances cannabis cultivation with unique aromas and traits.

People of Phylos Bioscience
Headcount 10-50
Employee Profiles 17
Board Members and Advisors 10
Employee Profiles
People
John McFerson
VP, Breeding
People
Nishan Karassik
Co-founder & CIO
People
Ralph Risch
Chief Executive Officer
People
Alisha Holloway
Chief Scientific Officer

Unlock access to complete

Board Members and Advisors
people
Lukas Mueller
Larry Smart, PhD
people
Sue Rhee
Advisor
people
Glenda Anderson
Advisor
people
Jeanne Sullivan
Advisor

Unlock access to complete

Funding Insights of Phylos Bioscience

Phylos Bioscience has successfully raised a total of $32M across 12 strategic funding rounds. The most recent funding activity was a Series B round of $3 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 12
  • Last Round Series B — $3.0M
  • First Round

    (20 Jan 2015)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2025 Amount Series B - Phylos Bioscience Valuation

investors

Dec, 2025 Amount Series B - Phylos Bioscience Valuation

investors

Oct, 2024 Amount Series D - Phylos Bioscience Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Phylos Bioscience

Phylos Bioscience has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Organigram, Merida Capital Partners and Accomplice. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Accomplice is engaged in venture capital investments for startups.
Founded Year Domain Location
Investment firm focused on cannabis industry growth and leadership.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Phylos Bioscience

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Phylos Bioscience

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Phylos Bioscience Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Phylos Bioscience

Phylos Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Benson Hill, Cibus, Ceres, Pairwise and Inari, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of plant-based food ingredients
domain founded_year HQ Location
Gene editing solutions are provided for agriculture.
domain founded_year HQ Location
Beers are produced and branded by Ceres in Italy.
domain founded_year HQ Location
New crop varieties are developed using gene-editing for agrigenomics.
domain founded_year HQ Location
Breeding technology is provided by Inari to design seeds.
domain founded_year HQ Location
Vertical farming and container solutions are developed through research.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Phylos Bioscience

Frequently Asked Questions about Phylos Bioscience

When was Phylos Bioscience founded?

Phylos Bioscience was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is Phylos Bioscience located?

Phylos Bioscience is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.

Is Phylos Bioscience a funded company?

Phylos Bioscience is a funded company, having raised a total of $32M across 12 funding rounds to date. The company's 1st funding round was a Series D of $1.81M, raised on Jan 20, 2015.

How many employees does Phylos Bioscience have?

As of Dec 31, 2020, the latest employee count at Phylos Bioscience is 61.

What does Phylos Bioscience do?

Phylos Bioscience was founded in 2014 in Portland, United States, within the biotechnology sector focused on cannabis. Tools for plant breeding and sex testing are offered, including kits and cards that detect the Y chromosome in plants aged seven to ten days. Services encompass genetic diagnostics, data analysis, and breeding resources tailored to cannabis cultivation for agricultural and health applications. Operations are centered on transformative plant genetics.

Who are the top competitors of Phylos Bioscience?

Phylos Bioscience's top competitors include Benson Hill, Cibus and Inari.

What products or services does Phylos Bioscience offer?

Phylos Bioscience offers F1 Hybrid Seeds and Natural THCV Products.

Who are Phylos Bioscience's investors?

Phylos Bioscience has 4 investors. Key investors include Organigram, Merida Capital Partners, Accomplice, and Entourage Effect Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available